Geneoscopy, a St. Louis-based developer of diagnostic tests for GI health, raised $105 million in Series B equity and debt funding, per Axios. Insiders Lightchain Capital and NT Investments co-led, and were joined by Morningside Ventures, Labcorp, Cultivation Capital, BioGenerator Ventures and Innovatus Capital Partners.
Related Posts
Knownwell Harvests $4.5M Seed Round
Flare Capital Partners led, and was joined by backers including Flybridge, Oxeon and Larry Summers.
January 19, 2023
Babylon Secures $61.5M in Private Placement Financing
The initial subscribers include the two largest existing Babylon institutional investors: entities affiliated with Kinnevik AB and VNV Global AB.
October 17, 2022
Wellvana Health Raises $84M to Drive Innovation in Value-Based Care
The investment was co-led by Nashville-based Heritage Group and Valtruis, a Welsh, Carson, Anderson & Stowe company, and joined by Memorial Hermann Health System.
March 28, 2023
Doc2Doc Lending Raises $35M in Equity and Debt
Of the total, the Atlanta-based platform raised $10 million in equity funding. Professional Solutions and others invested in the round.
August 16, 2023